CitroTech Inc.(CITR)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,493 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
CITR Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for CitroTech Inc. (CITR), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CITR at 30.3/100 on a 32-signal composite quality model, placing it at rank #2,493 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), CitroTech Inc. reports quarterly revenue of $280.7K, net income of $-3.9M, free cash flow of $-1.8M. Top institutional holders of CITR by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, FIFTH THIRD BANCORP, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. CITR trades on the NYSE exchange and files with the SEC under CIK 894556. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CITR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CitroTech Inc. directly from SEC EDGAR. CitroTech Inc.'s 13F Pro composite quality score has ranged between 24 and 30 since 2026, currently 30.3 — an improving long-term trajectory across 8 quarterly and live scoring snapshots.
Revenue
Q2 2026
$280.7K
Net Income
Q2 2026
$-3.9M
Free Cash Flow
Q2 2026
$-1.8M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+194.6% YoYNet Income
-435.3% YoYOperating Income
-211.0% YoYEPS (Diluted)
-261.0% YoYTotal Assets
+158.9% YoYTotal Debt
Op. Cash Flow
-202.9% YoYFree Cash Flow
-212.9% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $2.4M +194.6% | $808.4K +55.3% | $520.6K +730.0% | $62.7K | $0.00 | — |
| Net Income | $-36.8M -435.3% | $-6.9M +31.9% | $-10.1M -247.4% | $-2.9M -2961.7% | $-95.0K +13.2% | $-109.4K |
| Operating Income | $-16.5M -211.0% | $-5.3M +47.5% | $-10.1M -246.0% | $-2.9M -7598.9% | $-37.9K +65.3% | $-109.4K |
| EPS (Diluted) | $-2.96 -261.0% | $-0.82 | $0.00 | $0.00 | $0.00 | — |
| Total Assets | $14.2M +158.9% | $5.5M +3.3% | $5.3M +20.3% | $4.4M +1235.3% | $330.2K | $0.00 |
| Total Debt | — | $193.7K | $0.00 | — | — | — |
| Operating Cash Flow | $-5.9M -202.9% | $-1.9M -59.9% | $-1.2M -71.0% | $-708.5K -2826.8% | $-24.2K | $0.00 |
| Free Cash Flow | $-6.1M -212.9% | $-1.9M -59.4% | $-1.2M -70.3% | $-713.8K -2848.9% | $-24.2K | — |
Get alerted when CITR's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for CitroTech Inc. including:
Top Institutional Holders of CITR
VANGUARD CAPITAL MANAGEMENT LLC
$2.7M486,620 shFIFTH THIRD BANCORP
$1.3M235,281 shGEODE CAPITAL MANAGEMENT, LLC
$973.3K176,239 shLotus Technology Management, LP
$750.0K750,000 shCerity Partners LLC
$559.0K101,275 shVANGUARD FIDUCIARY TRUST CO
$522.3K94,625 shSTATE STREET CORP
$351.3K63,650 shT3 Companies, LLC
$226.2K40,983 shWEALTH ENHANCEMENT ADVISORY SERVICES, LLC
$211.1K40,825 shNORTHERN TRUST CORP
$209.6K37,969 sh
| Fund | Value | Shares |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $2.7M | 486,620 |
| FIFTH THIRD BANCORP | $1.3M | 235,281 |
| GEODE CAPITAL MANAGEMENT, LLC | $973.3K | 176,239 |
| Lotus Technology Management, LP | $750.0K | 750,000 |
| Cerity Partners LLC | $559.0K | 101,275 |
| VANGUARD FIDUCIARY TRUST CO | $522.3K | 94,625 |
| STATE STREET CORP | $351.3K | 63,650 |
| T3 Companies, LLC | $226.2K | 40,983 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $211.1K | 40,825 |
| NORTHERN TRUST CORP | $209.6K | 37,969 |
More Healthcare Companies
View all Healthcare →Put CITR on your watchlist
Track score changes the day CitroTech Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CITR a good stock to buy?
13F Pro's AI-powered analysis of CitroTech Inc. (CITR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CITR are available on the CITR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CITR is classified as a small company.
Which hedge funds own CITR?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CITR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CitroTech Inc.'s investment landscape.